In cancer genomes, frequent substitutions at glycosylation sites are apparent in epidermal growth factor receptors and oncogenes EGFR and ERBB3, as well as PAPPA, a secreted protein involved in the activation of insulin-like growth factor pathways (Lawrence et al., 1999). Here, ERBB3 is linked to cancer.